Mettler-Toledo
Precision instruments, inspection systems, and services for laboratories, factories, logistics, and food retail.
Something off on this page? Send us feedback.
Profile
Sells precision laboratory instruments, industrial weighing and automation systems, product-inspection equipment, retail scales, software, and related services. Laboratory products contribute most sales, while a global sales-and-service network supports research, quality-control, and manufacturing workflows in regulated customer industries.
Builds precision instruments and services across four product groups: Laboratory Instruments, Industrial Weighing and Automation, Product Inspection, and Retail Weighing Solutions. Laboratory offerings span balances, pipettes, titrators, analytical systems, process sensors, automation, and LabX software; industrial systems combine scales, terminals, data-capture, and control software; inspection equipment detects contaminants and verifies package weight, labels, and contents.
Sells globally through direct market organizations and distributors, with the Americas contributing the largest regional share and Europe and Asia and other countries each contributing substantial shares. A broad service organization generates revenue from the installed base through calibration, uptime, compliance, training, and replacement parts. Demand is tied to research, quality control, manufacturing, logistics, and food retail, while many products must meet weights-and-measures, electrical-safety, and customer-industry standards.
Company facts
Key statistics
Year to date −1.0% · Average volume (30d) 176.4K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Morgan Stanley | Reiterate | Equal Weight | $1,475 | $1,450 | |
| Aug 3, 2026 | Barclays | Reiterate | Overweight | $1,500 | $1,575 | |
| Aug 3, 2026 | Stifel Nicolaus | Target | $1,400 | $1,600 | ||
| Jul 31, 2026 | Jefferies | Reiterate | Buy | $1,100 | $1,580 | |
| Jul 6, 2026 | Evercore ISI | Reiterate | Outperform | $1,400 | $1,350 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $10.78 | $11.46 | +6.3% | $1.03B | $1.03B | 0.0% | +2.59% |
| May 7, 2026Q1 FY26 | $8.71 | $8.91 | +2.3% | $943.1M | $947.1M | +0.4% | −14.77% |
| Feb 5, 2026Q4 FY25 | $12.80 | $13.36 | +4.4% | $1.10B | $1.13B | +2.3% | −0.67% |
| Nov 6, 2025Q3 FY25 | $10.66 | $11.15 | +4.6% | $997.3M | $1.03B | +3.3% | −0.02% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $883.7M | $983.2M | $1.03B | $1.13B | $947.1M | $1.03B | |
| Gross profit | $508.7M | $562.3M | $589.4M | $655.8M | $555.8M | $650.2M | |
| Operating income | $219.5M | $265.7M | $289.9M | $343.3M | $246.2M | $306.6M | |
| Net income | $163.6M | $202.3M | $217.5M | $285.8M | $169.5M | $232.9M | |
| Diluted EPS | $7.84 | $9.77 | $10.57 | $14.02 | $8.35 | $11.55 | |
| Gross margin | 57.6% | 57.2% | 57.2% | 58.0% | 58.7% | 63.3% | |
| Operating margin | 24.8% | 27.0% | 28.2% | 30.4% | 26.0% | 29.8% |
Fiscal years (4-quarter sums)FY21 $3.72B · FY22 $3.92B · FY23 $3.79B · FY24 $3.87B · FY25 $4.03B
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $51.4M · Total debt $2.11B · Total assets $3.67B · Shareholders' equity $12.8M
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 20.21M · Float 20.06M · 99.3% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 1.88M | 9.32% | 13F | Aug 7, 2026 |
| Capital International Investors | 1.52M | 7.53% | 13F | Aug 12, 2026 |
| Vanguard Capital Management LLC | 1.32M | 6.53% | 13F | Aug 13, 2026 |
| Vanguard Portfolio Management | 1.01M | 5.01% | 13G | Jul 31, 2026 |
| State Street Corp | 951.7K | 4.71% | 13F | Aug 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 5, 2026 | Thomas P. Salice | director | −417 | $1,440.41 |
| Aug 3, 2026 | Shawn Vadala | officer: Chief Financial Officer | −2,240 | $1,432.00 |
| Aug 3, 2026 | Gerry Keller | officer: Head of Process Analytics | −240 | $1,427.14 |
| Aug 3, 2026 | Thomas P. Salice | director | −415 | $1,444.62 |
| Feb 10, 2026 | Shawn Vadala | officer: Chief Financial Officer | −800 | $1,410.12 |
Peers
- Agilent Technologies
Lab analytical instruments rival in pharma and chemical lab workflows.
- Waters
Focused HPLC/UPLC and thermal analysis rival in pharmaceutical lab workflows.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Mettler-Toledo | $1,398.58 | +0.05% | $28.26B | 31.4 | 28.2 | 6.8 | +4.5% |
| Agilent Technologies | $153.84 | +0.02% | $43.45B | 30.3 | 23.8 | 5.9 | +8.1% |
| Waters | $414.33 | −0.03% | $31.02B | 103.4 | 26.5 | 6.7 | +113.3% |
| Median | 66.8 | 25.2 | 6.3 | +60.7% |